Mar 8PrIMAVeRa participates in AMR Accelerator Cross-Project Meeting 2024March 2024 The Cross-Project Meeting gathered nearly 40 participants representing 9 Innovative Health Initiative (IHI)-funded projects...
Nov 24, 2023PrIMAVeRa provides in-depth reports on current evidence base of burden of AMR in EuropeThe PrIMAVeRa project proudly announces the simultaneous publication of four informative systematic reviews.
Nov 24, 2023PrIMAVeRa 2nd annual meeting successfully held in hybrid format in Utrecht on 15-16 November 2023The meeting enabled dynamic panel discussions covering the burden of AMR, and model development and data access.
Jun 19, 2023PrIMAVeRa Project Appoints Scientific Advisory CommitteeThe PrIMAVeRa project announces the appointment of the Scientific Advisory Committee (SAC).
Nov 30, 2022PrIMAVeRa 1st annual meeting successfully held in a hybrid event in Verona on 29-30 November 2022PrIMAVeRa team gathered for the first project annual meeting with around 30 project partners joining in Verona (IT), and virtually.
Feb 3, 2022PrIMAVeRa WP2 workshop, virtually held on 27-28 January 2022The 2-day workshop included an overview of WP2, presentation and discussion of AMR case studies, the draft of AMR protocol, and more.
Dec 15, 2021PrIMAVeRa kick-off meeting successfully marks the official project launchThe PrIMAVeRa consortium held its Kick-off Meeting on 25 November 2021 marking the official launch of this ambitious endeavor.
Nov 9, 2021PrIMAVeRa, an ambitious project to demonstrate how vaccines can combat AMRThe IMI2 Joint Undertaking mobilises more than € 9 million to harnessing the power of big data and AI to steer the fight against AMR